Innocan Pharma Corp (CSE: INNO )

0.2300 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EST, Nov 4, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
November 12, 2009
Form 8-K
Source: SEC/Edgar
November 04, 2009
Form 8-K
Source: SEC/Edgar
October 14, 2009
Form 8-K
Source: SEC/Edgar
October 13, 2009
Form 8-K
Source: SEC/Edgar
September 15, 2009
Form DEF 14A
Source: SEC/Edgar
September 09, 2009
Form PRE 14A
Source: SEC/Edgar
August 30, 2009
Form 8-K
Source: SEC/Edgar
July 14, 2009
Form 8-K
Source: SEC/Edgar
April 29, 2009
Form 8-K
Source: SEC/Edgar
April 26, 2009
Form NT 10-Q
Source: SEC/Edgar
April 14, 2009
Form 8-K
Source: SEC/Edgar
March 23, 2009
Form 8-K
Source: SEC/Edgar
March 16, 2009
Form NT 10-K
Source: SEC/Edgar
March 02, 2009
Form SC 13G/A
Source: SEC/Edgar
February 09, 2009
Form SC 13G
Source: SEC/Edgar
February 08, 2009
Form 8-K
Source: SEC/Edgar
January 06, 2009
Form SC 13D/A
Source: SEC/Edgar
December 14, 2008
Form 8-K
Source: SEC/Edgar
November 11, 2008
Form S-3
Source: SEC/Edgar
October 14, 2008
Form 8-K
Source: SEC/Edgar
October 14, 2008
Form DEF 14A
Source: SEC/Edgar
September 22, 2008
Form 8-K
Source: SEC/Edgar
July 14, 2008
Form 8-K
Source: SEC/Edgar
June 04, 2008
Form 8-K
Source: SEC/Edgar
April 13, 2008
Form 10-K/A
Source: SEC/Edgar
March 27, 2008
Form EFFECT
Source: SEC/Edgar
March 23, 2008
Form 424B3
Source: SEC/Edgar
March 23, 2008
Form SC 13D/A
Source: SEC/Edgar
March 11, 2008
Form S-3
Source: SEC/Edgar
February 28, 2008
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.